share_log

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K: Novo Nordisk A/S - Share Repurchase Programme

6-K：諾和諾德-股票回購計劃
美股SEC公告 ·  08/12 09:50
Moomoo AI 已提取核心訊息
Novo Nordisk A/S, a leading global healthcare company, has announced the initiation of a share repurchase program on August 7, 2024, as part of a larger 12-month buyback plan set to conclude on February 6, 2025. The current program, which follows the Safe Harbour Rules, involves the repurchase of B shares amounting to DKK 2.4 billion and will run until November 4, 2024. Since the start of the program, Novo Nordisk has bought back 130,250 B shares for a total of DKK 112,401,277. These transactions are separate from the company's incentive programs, which have seen a net transfer of 23,030 B shares. As a result, Novo Nordisk now holds 12,540,136 B shares as treasury shares, representing 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000 A and B shares. Novo Nordisk's stock is traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
Novo Nordisk A/S, a leading global healthcare company, has announced the initiation of a share repurchase program on August 7, 2024, as part of a larger 12-month buyback plan set to conclude on February 6, 2025. The current program, which follows the Safe Harbour Rules, involves the repurchase of B shares amounting to DKK 2.4 billion and will run until November 4, 2024. Since the start of the program, Novo Nordisk has bought back 130,250 B shares for a total of DKK 112,401,277. These transactions are separate from the company's incentive programs, which have seen a net transfer of 23,030 B shares. As a result, Novo Nordisk now holds 12,540,136 B shares as treasury shares, representing 0.3% of the share capital. The company's total share count, including treasury shares, stands at 4,465,000,000 A and B shares. Novo Nordisk's stock is traded on Nasdaq Copenhagen and its ADRs on the New York Stock Exchange.
全球領先的醫療保健公司諾和諾德已於2024年8月7日宣佈啓動股份回購計劃，該計劃爲期12個月，計劃在2025年2月6日結束。當前符合Safe Harbour Rules的計劃涉及回購DKK 24億的b股份，將在2024年11月4日前持續運行。自計劃開始以來，諾和諾德已經回購了1302500億股，總價值爲DKK 112,401,277。這些交易與公司的激勵計劃是分開的，激勵計劃已經淨轉讓了230300億股。因此，諾和諾德現在持有125401360億股作爲財務股份，佔持股總數的0.3％。公司的股票總數（包括財務股份）爲44.65億股A和B股。諾和諾德的股票在納斯達克哥本哈根上交易，其ADR在紐約證券交易所上市。
全球領先的醫療保健公司諾和諾德已於2024年8月7日宣佈啓動股份回購計劃，該計劃爲期12個月，計劃在2025年2月6日結束。當前符合Safe Harbour Rules的計劃涉及回購DKK 24億的b股份，將在2024年11月4日前持續運行。自計劃開始以來，諾和諾德已經回購了1302500億股，總價值爲DKK 112,401,277。這些交易與公司的激勵計劃是分開的，激勵計劃已經淨轉讓了230300億股。因此，諾和諾德現在持有125401360億股作爲財務股份，佔持股總數的0.3％。公司的股票總數（包括財務股份）爲44.65億股A和B股。諾和諾德的股票在納斯達克哥本哈根上交易，其ADR在紐約證券交易所上市。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息